Ependymal Tumor — Trials

Ependymal Tumor — Trials · CancerIndex

Clinical trials

Registered studies

151 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 51–100 of 151 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01795313	Immunotherapy for Recurrent Ependymomas in Children Using Tumor Antigen Peptides With Imiquimod	terminated	Phase 1	23	James FelkerOTHER	1	Feb 5, 2026	clinicaltrials
NCT05106296	Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer	recruiting	Phase 1	37	Theodore S. JohnsonOTHER	1	Jan 9, 2026	clinicaltrials
NCT04049669	Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG	active not recruiting	Phase 2	130	Theodore S. JohnsonOTHER	1	Jan 8, 2026	clinicaltrials
NCT06466798	Fourth Ventricular Administration of Immune Checkpoint Inhibitor (Nivolumab) and Methotrexate or 5-Azacytidine for Recurrent Medulloblastoma, Ependymoma, and Other CNS Malignancies

Data updated 22 days agoSource updated Feb 5, 2026source: clinicaltrials